Pharvaris N.V. (PHVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 48,208 | 41,677 | 37,026 | 30,738 | 29,264 |
| Operating Income | -48,208 | -41,677 | -37,026 | -30,738 | -29,264 |
| Interest Expense | 0 | 3,935 | -5,085 | -628 | 5,251 |
| Other Income | 12,605 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -35,602 | -45,612 | -31,941 | -30,110 | -34,515 |
| Income Tax | 1,336 | 253 | 76 | 310 | 808 |
| Net Income Continuous | -36,939 | -45,865 | -32,017 | -30,420 | -35,323 |
| Net Income | $-36,939 | $-45,865 | $-32,017 | $-30,420 | $-35,323 |
| EPS Basic Total Ops | -0.68 | -0.85 | -0.59 | -0.56 | -0.81 |
| EPS Basic Continuous Ops | -0.68 | -0.85 | -0.59 | -0.57 | -0.81 |
| EPS Diluted Total Ops | -0.68 | -0.85 | -0.59 | -0.56 | -0.81 |
| EPS Diluted Continuous Ops | -0.68 | -0.85 | -0.59 | -0.57 | -0.81 |
| EPS Diluted Before Non-Recurring Items | -0.68 | -0.85 | -0.59 | -0.56 | N/A |
| EBITDA(a) | $-48,112 | $-41,626 | $-36,953 | $-30,666 | $-29,194 |